Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older: a single-center experience with a literature review

BACKGROUND/AIMS: Among diffuse large B cell lymphoma (DLBCL) patients, determining the appropriate dose and chemotherapy schedule to balance toxicity and efficacy is harder in elderly than in younger patients. Moreover, there are no currently available clinical factors that consistently identify pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Yun Hwa, Woo, In Sook, Han, Chi Wha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578036/
https://www.ncbi.nlm.nih.gov/pubmed/26354063
http://dx.doi.org/10.3904/kjim.2015.30.5.684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578036/
https://www.ncbi.nlm.nih.gov/pubmed/26354063
http://dx.doi.org/10.3904/kjim.2015.30.5.684

Ejemplares similares